Lymphadenectomy in Urothelial Carcinoma in the Renal Pelvis and Ureter
Condition: Ureteral Neoplasms
Study Type: Interventional
Clinical Trials Identifier NCT 8-digits: NCT02607709
Sponsor: Zealand University Hospital
Eligibility:
- Age: minimum 18 Years maximum N/A
- Gender: All
Inclusion Criteria:
- Age above 18 years
- Locally advanced high grade urothelial carcinoma in the renal pelvis or upper 2/3 of the ureter (Clinical stage > T1)
- Patient with ECOG performance score of 2 and less.
- Able to give informed consent
Exclusion Criteria:
- Clinical suspicion of non-muscle invasive UUTUC
- Metastatic urothelial carcinoma for the renal pelvis or upper 2/3 of the ureter
- Inability to understand written consent forms or give consent
View trial on ClinicalTrials.gov